Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_provenance.
- NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_assertion description "[Vorinostat increased expression of genes down-regulated in MDS and/or AML (cFOS, COX2, IER3, p15, RAI3) and suppressed expression of genes over-expressed in these malignancies (AXL, c-MYC, Cyclin D1) and modulated cell cycle and apoptosis genes in a manner which would favor cell cycle arrest, differentiation, and apoptosis of neoplastic cells, consistent with the functional assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_provenance.
- NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_assertion evidence source_evidence_literature NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_provenance.
- NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_assertion SIO_000772 23320102 NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_provenance.
- NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_assertion wasDerivedFrom befree-20140225 NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_provenance.
- NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_assertion wasGeneratedBy ECO_0000203 NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP766333.RAgmlQeQrfDuAVQMXzKecArdFdq8LQ73l-jkc2kAAxKDU130_provenance.